
Downregulated ABCG2 Enhances Sensitivity to Topoisomerase I Inhibitor in Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor-Resistant Non-small Cell Lung Cancer
Keywords: سرطان ریه سلول غیر سلولی (NSCLC); Non-small cell lung cancer (NSCLC); Epidermal growth factor receptor tyrosine kinase inhibitor (EGFR TKI); Drug resistance; ABCG2; Topoisomerase I inhibitor